The study aims to characterise the influence of the autonomic nervous system activity on the development of the lipodystrophy syndrome in HIV-infected patients by measuring heart rate variability and various metabolic pathways in HIV patients receiving highly active antiretroviral therapy.

Patients with confirmed HIV infection and no active opportunistic infection during the last 2 months.

Criteria

Inclusion Criteria:

HIV-infection

Age above 18 years

No AIDS defining event during last 6 months

No infection during last 6 weeks

No concommitant drug interfering with insulin sensitivity and ANS-activity

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00149097